Skip to main content

Bronchoscopy Role in Interstitial Lung Disease

  • Chapter
  • First Online:
Interventions in Pulmonary Medicine

Abstract

Fiber-optic bronchoscopy is considered an important procedure in interstitial lung diseases (ILD) since it can lead to or discard a diagnosis in many cases. During the last years, the application of thoracic high-resolution computed tomography (HRCT) to ILD evaluation has enhanced the diagnostic approach, but cytological or histological study is often needed to make a confident ILD diagnosis. Frequently, bronchoalveolar lavage (BAL) and transbronchial lung biopsy (TBLB) play a significant role in making an accurate diagnosis of specific forms of ILD. However, the standardization of TBLB and BAL protocols, as well as the correct interpretation of thoracic HRCT for the procedure indication, is crucial for optimizing the usefulness of both techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med. 2001;7:255–61.

    Article  PubMed  CAS  Google Scholar 

  2. Travis WD, King TE, Bateman ED, et al. ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonias. General principles and recommendations. Am J Respir Crit Care Med. 2002;165:277–304.

    Google Scholar 

  3. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1–58.

    PubMed  Google Scholar 

  4. Xaubet A, Ancochea J, Blanquer R, Montero C, Morell F, Rodríguez Becerra E, Sueiro A, Villena V, Grupo de Investigación en Enfermedades Pulmonares Intersticiales Difusas. Area de Técnicas y Transplante. SEPAR. Diagnosis and treatment of diffuse interstitial lung diseases. Arch Bronconeumol. 2003;39(12):580–600.

    Article  PubMed  CAS  Google Scholar 

  5. Drent M, Meyer KC, Baughman RP. Bronchoalveolar lavage. Prog Respir Res. 2007;36:58–67.

    Article  Google Scholar 

  6. Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in the evaluating the patient with known or suspected ILD. Semin Roentgenol. 2010;45:3.

    Article  PubMed  Google Scholar 

  7. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007;28:546–60.

    Article  PubMed  Google Scholar 

  8. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25(4):v637–49.

    Article  Google Scholar 

  9. Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007;82(8):976–86.

    Article  PubMed  Google Scholar 

  10. Baughman RP. Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med. 2007;28:475–85.

    Article  PubMed  Google Scholar 

  11. Dhillon DP, Haslam PL, Townsend PJ, et al. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis. 1986;68:341–50.

    Google Scholar 

  12. Dohn MN, Baughman RP. Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis. 1985;132:390–2.

    PubMed  CAS  Google Scholar 

  13. Rosell A, Xaubet A, Agustí C, Castella J, Puzo C, Curull V, de Gracia J, RASTA Study Group. A new BAL fluid instillation and aspiration technique: a multicenter randomized study. Respir Med. 2006;100(3):529–35.

    Article  PubMed  Google Scholar 

  14. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J. 1992;5:776–9.

    PubMed  CAS  Google Scholar 

  15. Meyer KC, Soergel P. Bronchoalveolar lymphocyte phenotypes change in the normal aging human lung. Thorax. 1999;54:697–700.

    Article  PubMed  CAS  Google Scholar 

  16. Haslam PL, Baughmann RP. Guidelines for the measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev. 1999;9:25–157.

    Google Scholar 

  17. Baughman RP, Drent M. Role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2001;22:331–41.

    Article  PubMed  CAS  Google Scholar 

  18. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25:637–49.

    Article  PubMed  Google Scholar 

  19. Raghu G. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Con: bronchoalveolar lavage. J Bronchol. 1999;6:217–21.

    Article  Google Scholar 

  20. Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38(4):761–9.

    Article  PubMed  CAS  Google Scholar 

  21. Martin RJ, Coalson JJ, Roger RM, et al. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis. 1980;121:819–25.

    PubMed  CAS  Google Scholar 

  22. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med. 1994;150:1423–38.

    PubMed  CAS  Google Scholar 

  23. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.

    Article  PubMed  Google Scholar 

  24. Raghu G. Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011. Eur Respir J. 2011;37:743–6.

    Article  PubMed  CAS  Google Scholar 

  25. Welker L, Jörres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004;24:1000–6.

    Article  PubMed  CAS  Google Scholar 

  26. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007;28:486–95.

    Article  PubMed  Google Scholar 

  27. Costabel U, Guzman J, Bonella F, et al. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med. 2007;28:514–24.

    Article  PubMed  Google Scholar 

  28. Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, de Miguel Poch E, Delgado Nuñez M, Alfaro Abreu J. Safety of the transbronchial biopsy in outpatients. Chest. 1991;99:562–5.

    Article  PubMed  CAS  Google Scholar 

  29. Churg A. Transbronchial biopsy: nothing to fear. Am J Surg Pathol. 2001;25:820–2.

    Article  PubMed  CAS  Google Scholar 

  30. Margaritopoulos GA, Wells AU. The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: Con. Rev Port Pneumol. 2012;18(2):61–3.

    Article  PubMed  CAS  Google Scholar 

  31. Poletti V, Casoni GL, Cancellieri A, Piciucchi S, Dubini A, Zompatori M. Diffuse alveolar damage. Pathologica. 2012;102:453–63.

    Google Scholar 

  32. Leslie KO, Gruden JF, Parish JM, Scholand MB. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med. 2007;131(3):407–23.

    PubMed  Google Scholar 

  33. Colby TV, Fukuoka J, Ewaskow SP, Helmers R, Leslie KO. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol. 2001;5:309–19.

    Article  PubMed  CAS  Google Scholar 

  34. Oliveira CC, Fabro AT, Ribeiro SM, Defaveri J, Capelozzi VL, Queluz TH, Yoo HH. Evaluation of the use of transbronchial biopsy in patients with clinical suspicion of interstitial lung disease. J Bras Pneumol. 2011;37(2):168–75.

    PubMed  CAS  Google Scholar 

  35. Berbescu EA, Katzenstein AL, Snow JL, Zisman DA. Transbronchial biopsy in usual interstitial pneumonia. Chest. 2006;129:1126–31.

    Article  PubMed  Google Scholar 

  36. Martin WJ, Iannuzzi M, Gail DB, Peavy HH. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med. 2004;170:567–71.

    Article  PubMed  Google Scholar 

  37. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc. 2000;75:591–4.

    Article  PubMed  CAS  Google Scholar 

  38. Agostini C, Miorin M, Semenzato G. Gene expression profile analysis by DNA microarrays: a new approach to assess functional genomics in diseases. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:5–9.

    PubMed  Google Scholar 

  39. Thornhofer R, Maercker C, Popper HH. Expression of sarcoidosis related genes in lung lavage cells. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:59–65.

    Google Scholar 

  40. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188–98.

    Article  PubMed  CAS  Google Scholar 

  41. Magi B, Bini L, Perari MG, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis. 2002;23:3434–44.

    Article  PubMed  CAS  Google Scholar 

  42. Rottoli P, Magi B, Perari MG, et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics. 2005;5:1423–30.

    Article  PubMed  CAS  Google Scholar 

  43. De Torre C, Ying S, Munson PJ, et al. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics. 2006;6:3949–57.

    Article  PubMed  Google Scholar 

  44. Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest. 2006;130:567–74.

    Article  PubMed  CAS  Google Scholar 

  45. Pajares V, Torrego A, Puzo C, Lerma E, Gil De Bernabé MA, Franquet T. Transbronchial lung biopsy using cryoprobes. Arch Bronconeumol. 2010;46:111–5.

    Article  PubMed  Google Scholar 

  46. Babiak A, Hetzel J, Krishna G, et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration. 2009;78:203–8.

    Article  PubMed  Google Scholar 

  47. Franke KJ, Theegarten D, Hann von Weyhern C, et al. Prospective controlled animal study on biopsy sampling with new flexible cryoprobes versus forceps: evaluation of biopsy size, histological quality and bleeding risk. Respiration. 2010;80(2):127–32.

    Article  PubMed  Google Scholar 

  48. Griff S, Ammenwerth W, Schönfeld N, et al. Morphometrical analysis of transbronchial cryobiopsies. Diagn Pathol. 2011;16(6):53.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Molina-Molina M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Molina-Molina, M. (2013). Bronchoscopy Role in Interstitial Lung Disease. In: Díaz-Jimenez, J., Rodriguez, A. (eds) Interventions in Pulmonary Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6009-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6009-1_31

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6008-4

  • Online ISBN: 978-1-4614-6009-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics